Synthesis and Antioxidant Effects of Edaravone-Loaded MPEG-2000-DSPE Micelles in Rotenone-Induced PC12 Cell Model of Parkinson’s Disease

Xin Luo, Linshan Luo, Rong Lai, Yan Li, Hongyan Zhou, Xiting Li · 2024

Read Synthesis and Antioxidant Effects of Edaravone-Loaded MPEG-2000-DSPE Micelles in Rotenone-Induced PC12 Cell Model of Parkinson’s Disease by Xin Luo, Linshan Luo, Rong Lai, Yan Li, Hongyan Zhou, Xiting Li (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11643961.txt.

Description

Xin Luo and co-authors package the drug edaravone into tiny carrier spheres to treat a cell model of Parkinson's disease. The disease is the second most common neurodegenerative disorder, and no drug yet slows it. Edaravone scavenges free radicals and attacks several disease pathways, but it dissolves poorly and clears fast. The team wraps it in micelles built from a polymer-lipid carrier and characterizes the result.

They measure the spheres' shape, size, surface charge, and drug load. The test bed is a line of PC12 cells injured with rotenone, a standard Parkinson's model. Using viability counts, live-dead staining, and flow methods, they compare treated and untreated cells. Wound-healing tests track cell migration. A fluorescent probe measures reactive oxygen inside the cells, and mitochondrial membrane strength is checked. The study asks whether the packaged drug protects nerve-like cells better than the free drug.

Catalog record

CREATORXin Luo, Linshan Luo, Rong Lai, Yan Li, Hongyan Zhou, Xiting Li
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11643961

Browse the full library · About the Tower of Babel